LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2

Junjiro Saeki1, Shuichi Sekine, Toshiharu Horie

  • 1Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8675, Japan.

Biochemical Pharmacology
|September 28, 2010
PubMed

Insights

Lipopolysaccharide (LPS) causes liver injury by disrupting the interaction between multidrug resistance-associated protein 2 (Mrp2) and radixin, leading to Mrp2 internalization and cholestasis.

Area of Science:

  • Hepatology
  • Cell Biology
  • Biochemistry

Background:

  • Multidrug resistance-associated protein 2 (Mrp2) is crucial for bile flow, and its disruption is linked to liver failure and oxidative stress.
  • Previous studies showed Mrp2 internalization during acute oxidative stress and impaired colocalization with radixin in chronic liver failure.

Purpose of the Study:

  • To investigate the effect of lipopolysaccharide (LPS)-induced liver failure on radixin phosphorylation and its interaction with Mrp2.
  • To determine if LPS-induced cholestasis involves Mrp2 internalization via changes in radixin interaction and phosphorylation.

Main Methods:

  • Rats were treated with LPS to induce experimental liver failure and cholestasis.
  • Changes in canalicular expression of Mrp2 and radixin were assessed.
  • C-terminal phosphorylation of radixin (p-radixin) and its co-immunoprecipitation with Mrp2 were analyzed.

Main Results:

  • LPS treatment reduced canalicular Mrp2 and radixin expression.
  • The amount of active p-radixin and radixin co-immunoprecipitating with Mrp2 decreased after LPS treatment.
  • LPS impaired the protein-protein interaction between Mrp2 and radixin.

Conclusions:

  • LPS-induced cholestasis in rats is associated with decreased Mrp2 canalicular localization.
  • Disruption of the Mrp2-radixin interaction and radixin dephosphorylation contribute to Mrp2 internalization.
  • These findings suggest posttranscriptional regulation of Mrp2 in LPS-induced liver injury.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...